Company Profile
Public information reviewed
RIGEL PHARMACEUTICALS INC
Canonical company identity and public leadership record.
USNASDAQ: RIGL
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 22
- Last reviewed
- Sep 16, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/rigel-pharmaceuticals-inc.mdRIGEL PHARMACEUTICALS INC
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:d6cb82f8-d507-4607-98f2-ad7639b9735f |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/rigel-pharmaceuticals-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 25 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-16T04:46:04.746414+00:00 |
| Last reviewed | 2026-09-16T04:46:04.746414+00:00 |
Identity
- Legal name: RIGEL PHARMACEUTICALS INC
- Display name: RIGEL PHARMACEUTICALS INC
Leadership
- Alison L. Hannah: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Alison L. Hannah, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- David A. Santos: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Dean L. Schorno: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Gregg A. Lapointe: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Jane Wasman: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Kamil Ali-Jackson: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Kamil Ali-Jackson, J.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- Lisa Rojkjaer: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Mark W. Frohlich: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Mark W. Frohlich, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- Michael P. Miller: Director. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Raul R. Rodriguez: President, Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- Raymond J. Furey: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Walter H. Moos: Director. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2.
- Walter H. Moos, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- David A. Santos: Executive Vice President and Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- Dean L. Schorno: Executive Vice President and Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- Lisa Rojkjaer: Executive Vice President and Chief Medical Officer. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:4.
- Lisa Rojkjaer, M.D.: Executive Vice President and Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- Raul R. Rodriguez: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
- Raymond J. Furey: Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- PUBLISHED
Legal Name
- RIGEL PHARMACEUTICALS INC. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:1.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:1.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:1: Alpha canonical company public projection.
- alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:2: DEF 14A rigl-20260403.htm.
- alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:3: SEC DEF 14A 0001034842-26-000023.
- alpha:evidence:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:4: RIGL DEF 14A executive officers.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/rigel-pharmaceuticals-incat https://mcp.alpha.ac/mcp